• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Yesterday

    10/3/22 3:24:45 AM ET
    $AAN
    $AEHL
    $AEI
    $AIMD
    Diversified Commercial Services
    Consumer Discretionary
    Building Materials
    Industrials
    Get the next $AAN alert in real time by email

    Gainers

    • FingerMotion, Inc. (NASDAQ:FNGR) gained 82.2% to close at $3.37.
    • SAI.TECH Global Corporation (NASDAQ:SAI) gained 43.4% to close at $3.24 after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
    • F45 Training Holdings Inc. (NYSE:FXLV) shares gained 41.1% to close at $3.09 after a 13D filing showed the company received a non-binding proposal offer by one or more funds for a value of $4 per share.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares climbed 39% to close at $10.08. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
    • SOBR Safe, Inc. (NASDAQ:SOBR) gained 38.9% to close at $2.68 after the company announced it signed three reseller agreements with national distributors.
    • Ainos, Inc. (NASDAQ:AIMD) shares jumped 37% to close at $1.89 on Friday after the company reported results from the additional preclinical study of its low-dose oral interferon formulation against Omicron. The company reported VELDONA formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period.
    • Alset EHome International Inc. (NASDAQ:AEI) climbed 30.9% to close at $0.2562.
    • O2Micro International Limited (NASDAQ:OIIM) gained 30.2% to close at $4.23 after the company announced it entered into a definitive agreement for a "going private" transaction.
    • PolarityTE, Inc. (NASDAQ:PTE) surged 27.9% to close at $0.87.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) gained 27.8% to close at $2.30. The FDA granted 510(k) clearance to the company’s CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III.
    • VectivBio Holding AG (NASDAQ:VECT) jumped 26.1% to close at $6.00.
    • Vincerx Pharma, Inc. (NASDAQ:VINC) surged 25.5% to close at $1.38.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) gained 23.9% to settle at $3.22.
    • PLx Pharma Inc. (NASDAQ:PLXP) surged 23.7% to close at $0.65.
    • Waldencast plc (NASDAQ:WALD) rose 19.9% to close at $10.00.
    • Stabilis Solutions, Inc. (NASDAQ:SLNG) gained 19.3% to settle at $7.74.
    • Nemaura Medical Inc. (NASDAQ:NMRD) surged 18.9% to close at $2.08. Nemaura and EVERSANA recently signed a preliminary agreement for large-scale launch of Nemaura's diabetes management program in the US.
    • IGM Biosciences, Inc. (NASDAQ:IGMS) climbed 17% to close at $22.74.
    • FG Financial Group, Inc. (NASDAQ:FGF) gained 16.6% to settle at $FG Financial Group, Inc. (FGF).
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) climbed 14.9% to close at $6.59. InMed recently reported a FY22 net loss of $33.17 per share.
    • X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) gained 14.8% to close at $1.71. X4 Pharmaceuticals recently announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) rose 14.3% to close at $34.05. Akero Therapeutics recently released topline data from HARMONY Phase 2b study of efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), fibrosis stage 2 or 3 (F2-F3).
    • Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) gained 13.7% to close at $15.96 after the company reported clinical updates from its Phase 1 Danon Disease Trial for RP-A501m which showed initial improvements across clinical, functional and biomarker endpoints. Evercore ISI raised its price target from $65 to $75.
    • Harpoon Therapeutics, Inc. (NASDAQ:HARP) gained 13.5% to settle at $0.97.
    • Athersys, Inc. (NASDAQ:ATHX) gained 13.5% to close at $1.85. Athersys recently announced it entered into amended agreements to extend the exercise period of the warrants that were issued as part of a recent registered direct offering.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) surged 12.8% to close at $1.76. Snow Lake Resources issued filing showing the company has requested for withdrawal of registration statement in regards to its previously announced public offering.
    • Innovid Corp. (NYSE:CTV) gained 12% to settle at $2.71.
    • Quanterix Corporation (NASDAQ:QTRX) jumped 11.8% to close at $11.02.
    • MoneyLion Inc. (NYSE:ML) rose 11.1% to close at $0.8926. MoneyLion responded to Consumer Financial Protection Bureau’s meritless complaint.
    • bluebird bio, Inc. (NASDAQ:BLUE) rose 11.1% to close at $6.33. bluebird bio recently named Katherine Breedis as interim CFO.
    • Benson Hill, Inc. (NYSE:BHIL) gained 10.9% to close at $2.74 after UBS initiated coverage on the stock with a Buy rating and $5 price target.
    • Daseke, Inc. (NASDAQ:DSKE) climbed 10.6% to close at $5.41 after the company announced a $40 million stock repurchase program.
    • MINISO Group Holding Limited (NYSE:MNSO) surged 10.2% to close at $5.49. MINISO Group’s board of directors recently authorized and approved a new share repurchase program.
    • Poshmark, Inc. (NASDAQ:POSH) jumped 9.9% to close at $15.67.
    • Immuneering Corporation (NASDAQ:IMRX) gained 9.2% to close at $14.32. Immuneering announced FDA clearance of IND application for Phase 1/2a clinical trial of IMM-1-104 to treat advanced solid tumors with RAS mutations.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) rose 6.6% to close at $0.65 after declining over 6% on Thursday. Iveda Solutions, last month, announced a $5 million private placement.
    • IonQ, Inc. (NYSE:IONQ) gained 6.1% to close at $5.07 after the company announced it secured a contract to provide quantum solutions to the U.S. Air Force Research Lab.
    • Charles River Laboratories International, Inc. (NYSE:CRL) gained 3.6% to close at $196.80 after Jefferies upgraded the stock from Hold to Buy and announced a $240 price target.

     

    Losers

    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) dipped 39.9% to settle at $20.40 on Friday.
    • Aterian, Inc. (NASDAQ:ATER) fell 37.1% to close at $1.24 after the company priced a 10,526,368 share registered direct offering at $1.90 per share.
    • Edesa Biotech, Inc. (NASDAQ:EDSA) declined 34.7% to close at $0.9213. Edesa Biotech reported statistically significant mortality reductions in Phase 2 ARDS drug study.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) dropped 32.4% to close at $0.2016. AVCT announced intent to effect reverse stock split.
    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) shares fell 30.5% to close at $0.6256 on Friday after the company announced pricing of a $1 million registered direct offering.
    • FedNat Holding Company (NASDAQ:FNHC) dipped 27.6% to close at $0.1150.
    • 5E Advanced Materials Inc. (NASDAQ:FEAM) fell 27.6% to close at $10.16.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) dropped 24.7% to close at $0.2703 after the company priced a common stock offering of 20.1 million shares at $0.30 per share.
    • OpGen, Inc. (NASDAQ:OPGN) dipped 24% to close at $0.2862 after the company announced a $3.38 million registered direct offering.
    • Carnival Corporation (NYSE:CCL) fell 23.3% to close at $7.03 after the company reported worse-than-expected Q3 EPS and sales results.
    • Kuke Music Holding Limited (NYSE:KUKE) dropped 22.3% to close at $0.4710. Kuke Music Holding filed for mixed shelf of up to $100 million.
    • Rent-A-Center Inc (NASDAQ:RCII) fell 21.6% to close at $17.51 as the company lowered its earnings guidance for the third quarter and named Mr. Fahmi Karam as new Executive Vice President - Chief Financial Officer.
    • SHF Holdings Inc (NASDAQ:SHFS) fell 20% to close at $6.99 after declining 15% on Thursday. Northern Lights Acquisition completed business combination of SHF, Safe Harbor Financial, which offers compliance services to financial institutions that serve the regulated cannabis industry.
    • COMSovereign Holding Corp. (NASDAQ:COMS) dropped 19.9% to close at $0.0768.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 19.4% to close at $0.4799.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) dropped 19.1% to close at $4.15. Ocular Therapeutix 10%+ owner Summer Road LLC reported purchase of 150,000 at an average price of $4.59 per share in Form 4 filing on Thursday.
    • Century Aluminum Company (NASDAQ:CENX) dipped 18.3% to close at $5.28 after Wolfe Research downgraded the stock from Peer Perform to Underperform.
    • TH International Ltd (NASDAQ:THCH) declined 18% to close at $5.98.
    • Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) dropped 18% to close at $11.36 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
    • Terran Orbital Corporation (NYSE:LLAP) fell 17.7% to settle at $1.77.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) dipped 17.3% to close at $2.24.
    • Reading International, Inc. (NASDAQ:RDIB) fell 15.8% to close at $18.70.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) dropped 15.3% to close at $27.45.
    • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares fell 15% to close at $13.95 after the company announced its REVERSE Phase 3 study of obeticholic acid did not meet its primary endpoint.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) dropped 14.8% to close at $1.61.
    • Mondee Holdings, Inc. (NASDAQ:MOND) fell 14.5% to close at $7.81.
    • Airspan Networks Holdings Inc. (NASDAQ:MIMO) dropped 14% to close at $2.02.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) fell 14% to close at $0.3614.
    • Royal Caribbean Cruises Ltd. (NYSE:RCL) fell 13.2% to close at $37.90 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) dropped 13.1% to close at $1.72.
    • NIKE, Inc. (NYSE:NKE) fell 12.8% to close at $83.12. NIKE reported better-than-expected earnings and sales results for its first quarter on Thursday. However, the company reported a rise in quarter-ended inventories and revenue in the Greater China region also declined from a year ago.
    • GigaCloud Technology Inc. (NASDAQ:GCT) dipped 11.8% to close at $10.11. GigaCloud Technology reported second-quarter FY22 sales growth of 11% year-on-year to $124 million.
    • Karat Packaging Inc. (NYSE:KRT) dropped 11.4% to close at $15.99.
    • Worthington Industries, Inc. (NYSE:WOR) declined 11.3% to settle at $38.14. BMO Capital maintained Worthington Industries with a Market Perform and lowered the price target from $58 to $52.
    • HilleVax, Inc. (NASDAQ:HLVX) fell 11.2% to close at $17.09.
    • Pintec Technology Holdings Limited (NASDAQ:PT) fell 11% to close at $0.27.
    • Under Armour, Inc. (NYSE:UAA) dipped 9.8% to settle at $6.65.
    • ContextLogic Inc. (NASDAQ:WISH) fell 9.6% to close at $0.7339.
    • Li-Cycle Holdings Corp. (NYSE:LICY) dropped 9.5% to close at $5.32. Morgan Stanley maintained Li-Cycle Holdings with an Equal-Weight and lowered the price target from $8 to $7.
    • Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) dropped 9.1% to close at $6.76.
    • Belpointe PREP, LLC (NYSE:OZ) dipped 9.1% to settle at $84.45.
    • AMTD Digital Inc. (NYSE:HKD) fell 8.2% to close at $46.80.
    • The Aaron's Company, Inc. (NYSE:AAN) dropped 7.5% to settle at $9.72.
    • DICK'S Sporting Goods, Inc. (NYSE:DKS) fell 7.4% to close at $104.64. Shares of retail and apparel companies at large traded lower in sympathy with Nike, which fell after the company reported first-quarter financial results.
    • Lululemon Athletica Inc. (NASDAQ:LULU) dipped 6.9% to close at $279.56 in sympathy with Nike, which fell after the company reported first-quarter financial results.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) fell 6.8% to close at $28.15 as the stock pulled back after gaining following FDA approval of RELYVRIO for ALS..
    Get the next $AAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAN
    $AEHL
    $AEI
    $AIMD

    CompanyDatePrice TargetRatingAnalyst
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Under Armour Inc.
    $UAA
    2/10/2026$6.20Neutral → Sell
    Citigroup
    Under Armour Inc.
    $UAA
    2/9/2026$5.00 → $6.00Market Perform
    Telsey Advisory Group
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    1/20/2026$40.00 → $28.00Overweight
    Analyst
    Waldencast plc
    $WALD
    1/14/2026$2.00Buy
    Jefferies
    Nike Inc.
    $NKE
    1/8/2026Hold
    Deutsche Bank
    lululemon athletica inc.
    $LULU
    1/8/2026Hold
    Deutsche Bank
    More analyst ratings

    $AAN
    $AEHL
    $AEI
    $AIMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Pujol Henry L was granted 11,357 shares and covered exercise/tax liability with 4,202 shares, increasing direct ownership by 97% to 14,509 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:07:03 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    President & CEO Liberty Jason T was granted 296,251 shares and covered exercise/tax liability with 111,299 shares, increasing direct ownership by 148% to 309,732 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:06:05 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SVP, CLO, Secretary & CCO Lake Robert Alexander was granted 30,510 shares and covered exercise/tax liability with 11,586 shares, increasing direct ownership by 97% to 38,449 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:04:49 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bep Special Situations Iv Llc bought $8,000,000 worth of shares (4,000,000 units at $2.00) (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/4/26 4:30:07 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    CFO Malm Joshua bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 263% to 5,175 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:48 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Chief Executive Officer Weibel Paul Wesley Iii bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 25% to 18,838 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:16 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    $AAN
    $AEHL
    $AEI
    $AIMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XOLREMDI issued to X4 PHARMACEUTICALS INC

    Submission status for X4 PHARMACEUTICALS INC's drug XOLREMDI (ORIG-1) with active ingredient MAVORIXAFOR has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218709, Application Classification: Type 1 - New Molecular Entity

    4/29/24 2:36:51 PM ET
    $XFOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 29, 2022 - FDA Approves New Treatment Option for Patients with ALS

    For Immediate Release: September 29, 2022 The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.  “This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure,” said Billy Dunn, M.D., director of the Off

    9/29/22 5:02:14 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAN
    $AEHL
    $AEI
    $AIMD
    SEC Filings

    View All

    SEC Form 6-K filed by Snow Lake Resources Ltd.

    6-K - Snow Lake Resources Ltd. (0001769697) (Filer)

    2/13/26 7:36:12 AM ET
    $LITM
    Other Metals and Minerals
    Basic Materials

    SEC Form FWP filed by Royal Caribbean Cruises Ltd.

    FWP - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Subject)

    2/12/26 5:08:47 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Norwegian Cruise Line Holdings Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Norwegian Cruise Line Holdings Ltd. (0001513761) (Filer)

    2/12/26 4:20:30 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Snow Lake Completes Acquisition of Global Uranium and Enrichment Limited

    Acquisition advances Snow Lake's strategic objective to establish a nuclear fuel cycle companyWinnipeg, Manitoba--(Newsfile Corp. - February 13, 2026) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ:LITM) ("Snow Lake"), a nuclear fuel cycle company, announces that it has successfully completed the acquisition (the "Acquisition") of Global Uranium and Enrichment Limited ("GUE"). The Acquisition significantly expands Snow Lake's uranium assets and investments, and advances its strategy to develop nuclear fuel cycle capabilities in the U.S.The Acquisition consolidates within Snow Lake:A portfolio of U.S. uranium exploration and development projects containing substantial existing ur

    2/13/26 7:30:00 AM ET
    $LITM
    Other Metals and Minerals
    Basic Materials

    Royal Caribbean Group announces pricing of $1.25 billion senior unsecured notes due 2033 and $1.25 billion senior unsecured notes due 2038

    MIAMI, Feb. 12, 2026 /PRNewswire/ -- Royal Caribbean Cruises Ltd. (NYSE:RCL) (the "Company") today announced that it has priced a registered public offering of $1.25 billion aggregate principal amount of 4.750% senior unsecured notes due 2033 (the "2033 Notes") and $1.25 billion aggregate principal amount of 5.250% senior unsecured notes due 2038 (the "2038 Notes" and, together with the 2033 Notes, the "Notes"). The 2033 Notes will mature on May 15, 2033 and the 2038 Notes will mature on February 27, 2038. The Notes are expected to be issued on or around February 27, 2026, subject to the satisfaction of customary closing conditions.

    2/12/26 5:03:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Norwegian Cruise Line downgraded by Barclays with a new price target

    Barclays downgraded Norwegian Cruise Line from Overweight to Equal Weight and set a new price target of $23.00

    2/11/26 7:50:17 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Under Armour downgraded by Citigroup with a new price target

    Citigroup downgraded Under Armour from Neutral to Sell and set a new price target of $6.20

    2/10/26 8:00:29 AM ET
    $UAA
    Apparel
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Under Armour with a new price target

    Telsey Advisory Group reiterated coverage of Under Armour with a rating of Market Perform and set a new price target of $6.00 from $5.00 previously

    2/9/26 6:49:53 AM ET
    $UAA
    Apparel
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Leadership Updates

    Live Leadership Updates

    View All

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Oceania Cruises® Celebrates Keel Laying for New-Generation Ship, Oceania Sonata™, at the Fincantieri Shipyard in Marghera, Italy

    Oceania Sonata is the First of Four New Sonata Class Vessels for the Luxury Line MIAMI, Feb. 5, 2026 /PRNewswire/ -- Oceania Cruises®, the world's leading culinary- and destination-focused luxury cruise line, has celebrated a pivotal milestone in the construction of its next-generation ship, Oceania Sonata™, as the keel of the ship was laid at the Fincantieri shipyard in Marghera, Italy. The ceremony, an important maritime tradition, honored the rich heritage of shipbuilding, the importance of partnership, and underscored the line's bold vision of its future. "Oceania Sonata e

    2/5/26 8:30:00 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Oceania Cruises® Celebrates Record-Breaking Launch Day for Brand New Ship

    Oceania Sonata™ Outperformed the Previous Record Launch Day for a New Ship by 45% MIAMI, Feb. 2, 2026 /PRNewswire/ -- Oceania Cruises®, the world's leading culinary- and destination-focused luxury cruise line, achieved record-breaking booking levels on January 28, 2026, the opening day of reservations for its newest ship, Oceania Sonata. This surpassed the launch-day bookings of Oceania Cruises' previous new ship, Oceania Allura™, by an impressive 45%. Demand for Oceania Sonata's inaugural season was brisk, with exceptional demand across the suite categories, underscoring Ocea

    2/2/26 4:17:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Financials

    Live finance-specific insights

    View All

    Norwegian Cruise Line Holdings to Hold Conference Call on Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) (together with NCL Corporation Ltd., "Norwegian Cruise Line Holdings" or the "Company") announced today it will report fourth quarter and full year 2025 financial results on Monday, March 2, 2026 at 6:30 a.m. Eastern Time with a conference call and webcast to discuss results at 8:00 a.m. Eastern Time. The conference call will be webcast via the Company's Investor Relations website, https://www.nclhltd.com/investors. A replay of the webcast will be available here on the Company's website for 30 days following the call. About Norwegian Cruise Line Holdings Ltd. Norwegian Cruise Line Holdings Ltd. (NYS

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Royal Caribbean Group Raises Dividend Fifty Percent

    MIAMI, Feb. 10, 2026 /PRNewswire/ -- The Board of Directors of Royal Caribbean Group (NYSE:RCL) today declared a quarterly dividend of $1.50 per common share payable on April 3, 2026 to shareholders of record at the close of business on March 6, 2026.  "This dividend increase reflects the continued strength of our business and the momentum across our global vacation portfolio," said Jason Liberty, President and CEO. "This step underscores our commitment to delivering meaningful returns to our shareholders while continuing to invest in the innovations and experiences that defin

    2/10/26 4:30:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    DICK'S Sporting Goods, Inc. Fourth Quarter Results Call Scheduled for March 12th

    PITTSBURGH, Feb. 6, 2026 /PRNewswire/ -- DICK'S Sporting Goods, Inc. (NYSE:DKS) will announce results for the fourth quarter and full year 2025 before the market opens on Thursday, March 12th.      A conference call to discuss the results will be held that day at 10:00 a.m. Eastern Time. The call is being webcast and can be accessed at DICK'S Sporting Goods' Investor Relations website at investors.dicks.com. To listen to the live call, please go to the website at least fifteen minutes early to register and download and install any necessary audio software. A playback of the ca

    2/6/26 8:00:00 AM ET
    $DKS
    Other Specialty Stores
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Stabilis Solutions Inc. on Jun 7 Indicate?

    Recently, on June 7, 2024, a notable insider purchase occurred at Stabilis Solutions Inc., as reported in a Form 4 filing by Puhala Andrew Lewis. Mr. Lewis purchased $4,150 worth of shares, acquiring 1,000 units at $4.15 per share. This transaction increased his direct ownership by 3% to 33,618 units. Insider transactions such as this one can provide valuable insights for investors, signaling confidence or positive sentiment from those within the company. Examining the historical insider transactions at Stabilis Solutions Inc., several interesting patterns emerge. In a previous Form 4 filed on May 2, 2023, Puhala Andrew Lewis initiated his ownership stake. This was followed by filings from

    6/10/24 12:45:26 AM ET
    $SLNG
    Oil/Gas Transmission
    Utilities

    $AAN
    $AEHL
    $AEI
    $AIMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Pharmaceuticals Inc.

    SC 13D/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject)

    12/16/24 7:51:51 PM ET
    $RCKT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by MoneyLion Inc.

    SC 13D/A - MONEYLION INC. (0001807846) (Subject)

    12/10/24 5:27:46 PM ET
    $ML
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Li-Cycle Holdings Corp.

    SC 13D/A - Li-Cycle Holdings Corp. (0001828811) (Subject)

    12/9/24 6:03:27 PM ET
    $LICY
    Environmental Services
    Industrials